Expert Opinion by: Dr Steve Furniss, Consultant Cardiologist, East Sussex Healthcare TrustView More NICE- Atrial Fibrillation Guidelines
Summary taken directly from the American College of Cardiology Quick Takes Patients with AF who use wearable devices for detection of AF are more than…View More Impact of wearable devices on clinical outcomes and health care utilisation in AF patients
Taken directly from the American College of Cardiology One glass of wine, beer or other alcoholic beverage may significantly increase the risk of an atrial…View More HOLIDAY Monitors: Alcohol Consumption Significantly Increases Risk of AFib Episode
Key changes: Bleeding risk scoreNew NICE guideline recommends using the ORBIT bleeding risk score but equally recognises that existing bleeding risk scores may still be…View More NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation
By Ahmed El-Medany Among atrial fibrillation (AF) patients, inflammatory markers strongly predict heart failure (HF) hospitilisation. Benz et al analysed 3,784 individuals with AF (median…View More Inflammatory biomarkers linked with heart failure hospitalisation in atrial fibrillation
By Ahmed El-Medany This pioneering in vivo study by Saglietto et al investigated beat-to-beat microcirculatory perfusion during atrial fibrillation (AF) by using near-infrared spectroscopy to…View More Atrial fibrillation increases beat-to-beat variability of cerebral microcirculatory perfusion – a potential target for reducing long-term cognitive decline?
By Ahmed El-Medany A retrospective cohort study by Dawwas et al reports that DOACs, compared with warfarin, were associated with lower risks for ischemic stroke…View More DOACs vs. warfarin in valvular atrial fibrillation
Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve